MiR-497 Suppresses Angiogenesis and Metastasis of Hepatocellular Carcinoma by Inhibiting VEGFA and AEG-1
Overview
Authors
Affiliations
Hepatocellular carcinoma (HCC) is a worldwide malignance and displays marked vascular abnormalities and active metastasis. MicroRNAs (miRNAs) have been shown to play important roles in regulating tumor properties in cancer, however, whether miR-497 contributes to HCC angiogenesis or metastasis remains unclear. In this study, we found that miR-497 was significantly down-regulated in HCC tissue samples and cell lines. Gain-of-function and loss-of-function studies revealed that miR-497 could repress both the pro-angiogenic and metastatic ability of HCC cells. Subsequent investigations disclosed that miR-497 directly inhibited the 3'-untranslated regions (UTRs) of vascular endothelial growth factor A (VEGFA) and astrocyte elevated gene-1 (AEG-1). Furthermore, overexpression of these targets antagonized the function of miR-497. Based on nude mouse models, we demonstrated that overexpression of miR-497 significantly repressed microvessel densities in xenograft tumors and reduced pulmonary metastasis. In conclusion, our findings indicate that miR-497 downregulation contributes to angiogenesis and metastasis in HCC.
Rahdan F, Saberi A, Saraygord-Afshari N, Hadizadeh M, Fayeghi T, Ghanbari E Heliyon. 2024; 10(20):e39489.
PMID: 39498055 PMC: 11532857. DOI: 10.1016/j.heliyon.2024.e39489.
MicroRNA as Key Players in Hepatocellular Carcinoma: Insights into Their Role in Metastasis.
Saadh M, Hussain Q, Alazzawi T, Fahdil A, Athab Z, Yarmukhamedov B Biochem Genet. 2024; .
PMID: 39103713 DOI: 10.1007/s10528-024-10897-0.
A Meta-Analysis of MiRNA-497 and Prognosis of Hepatocellular Carcinoma.
Xie Z, Hao Q, Zhu R, Ma R Can J Gastroenterol Hepatol. 2024; 2024:2211179.
PMID: 38529202 PMC: 10963114. DOI: 10.1155/2024/2211179.
Clinical significance of exosomal noncoding RNAs in hepatocellular carcinoma: a narrative review.
Yoo J, Kang M J Yeungnam Med Sci. 2024; 42:4.
PMID: 38325815 PMC: 11812098. DOI: 10.12701/jyms.2023.01186.
Role of Angiogenesis and Its Biomarkers in Development of Targeted Tumor Therapies.
Pathak A, Pal A, Roy S, Nandave M, Jain K Stem Cells Int. 2024; 2024:9077926.
PMID: 38213742 PMC: 10783989. DOI: 10.1155/2024/9077926.